US officials are seeking to curb pharmaceutical companies' practice of advertising prescription drugs directly to consumers, a move backed by a health economist.
US FDA Approves Signos Glucose Monitoring System for Weight ManagementOn August 22, 2025, the U.S. Food and Drug Administration granted clearance to the Signos Glucose Monitoring System. This over-the-counter glucose monitoring system has been developed specifically for weight management.
Integration of Advanced Technology in SignosSignos…